Hyperkalemia and chronic kidney disease
Journal Title: Нирки - Year 2019, Vol 8, Issue 1
Abstract
Chronic hyperkalemia is a major complication of chronic kidney disease (CKD) that occurs frequently, heralds poor prognosis, and necessitates careful management by the nephrologist. Current strategies aimed at prevention and treatment of hyperkalemia are still suboptimal, as evidenced by the relatively high prevalence of hyperkalemia in patients under stable nephrology care, and even in the ideal setting of randomized trials where best treatment and monitoring are mandatory. The aim of this review was to identify and discuss a range of unresolved issues related to the management of chronic hyperkalemia in CKD. The following topics of clinical interest were addressed: diagnosis, relationship with main comorbidities of CKD, therapy with renin-angiotensin-aldosterone system inhibitors, efficacy of current dietary and pharmacological treatment, and the potential role of the new generation of potassium binders.
Authors and Affiliations
S. V. Kushnirenko
Keywords
Related Articles
- EP ID EP473971
- DOI 10.22141/2307-1257.8.1.2019.157791
- Views 89
- Downloads 0
Cystatin C and chronic kidney disease in children
Background. Determination of diagnostically significant values of serum concentration of cystatin C in combination with the estimated glomerular filtration rate (GFR) gives clinicians an advantage in clearly differentiat...
Diagnostic role of radionuclide renography in patients with renovascular hypertension
Background. Arterial hypertension due to the pathology of the renal artery, according to recent years, is observed in 10–15 % of patients with hypertensive disease; in 30 % of patients, it has a nephrogenic origin. The p...
Predictors of chronic heart failure development and progression in pre-dialysis patients with chronic kidney disease
Chronic kidney disease leads to early damage to the heart and blood vessels with the development of heart failure. The manifestation of one disease leads to the progression of another, since chronic heart failure is a co...
Nephrotic Syndrome or Paraneoplastic Nephropathy in Shereshevsky — Turner Syndrome?
.
Correction of Potentially Modified Risk Factors in Hemodialysis Treatment: Standards of Therapy and Individualized Programs of Dialysis
Limitations of possible correction for potentially modified factor the risk of death of patients, who are on renal replacement therapy, by techniques of hemodialysis were studied. The conclusions about the possibility of...